AstraZeneca said Monday that late stage trials of its COVID-19vaccine developed with Oxford University were “highlyeffective’’ in preventing disease. The results are based oninterim analysis of trials … Click to Continue »
by Brian Rogers
AstraZeneca said Monday that late stage trials of its COVID-19vaccine developed with Oxford University were “highlyeffective’’ in preventing disease. The results are based oninterim analysis of trials … Click to Continue »